Anthony Fauci says he will cooperate fully with possible House Republican investigation into Covid origins

Anthony Fauci says he will cooperate fully with possible House Republican investigation into Covid origins


Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks about the coronavirus during the White House press briefing on Tuesday, November 22, 2022.

Tom Williams | Cq-roll Call, Inc. | Getty Images

CNBC Health & Science

Read CNBC’s latest global health coverage:

U.S. intelligence agencies under the Biden administration, in an assessment published in August 2021, were split about the most likely origin.

One agency had moderate confidence that the virus infected people after a lab incident, while four agencies assessed with low confidence that the virus had a natural origin, according to the assessment, which did not identify those agencies.

Earlier this year, Fauci announced that he will step down in December after leading the National Institute of Allergy and Infectious Diseases for nearly 40 years.

For decades, Fauci was respected as a public health servant on both sides of the political aisle.

But as the response to the pandemic became increasingly politicized under then-President Donald Trump, a Republican, Fauci became a lightning rod for many conservatives in Congress.

In addition to arguing with them over the origins of the virus, Fauci has also repeatedly clashed with Republicans in Congress over mask and vaccine policy.



Source

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say
Health

Making U.S. biotech more competitive with China’s could help rare disease patients, experts say

The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and helping launch a new wave of labs and incubators in the country. That’s a problem for the U.S. biotech industry and also affects rare disease patients who are waiting for a cure. Among the experts […]

Read More
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference
Health

Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good morning from San Francisco! It’s day three of the annual JPMorgan Healthcare Conference – the biggest gathering of biotech and pharma execs, investors and analysts in […]

Read More
OpenAI acquires health-care technology startup Torch
Health

OpenAI acquires health-care technology startup Torch

OpenAI has acquired the health-care technology startup Torch, the company announced on Monday. Torch was building a “unified medical memory” for artificial intelligence that aimed to bring a patient’s health data, which is typically siloed and stored across a number of different vendors and formats, into one place. Torch’s employees will join OpenAI as part […]

Read More